Home > Drug Search >
  • company_query: Beijing Fengshuo Weikang
  •   > 
Drug Filter
Category:
chemistry (27) biology (6)
Status:
Approved (2) BLA Filing (1) Phase Ⅲ (2) Phase Ⅱ (11) Phase Ⅰ (13) IND Filing (4)
Clinical Stage:
Pending (2) Active (23) Discontinued (4)
Bio-Type:
Vaccine (2) Recombinant cytokines (1) Whole antibody (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Anemia (2) Asthma (2) Breast cancer (3) Community-acquired pneumonia (CAP) (1) Deep vein thrombosis (DVT) (1) Depression (1) Diabetic macular edema (1) Dry eye disease (1) Duodenal ulcer (1) Erectile dysfunction (ED) (1) Gastric cancer (2) Gastric ulcer (1) Opioid central depression (1) Hypertension (1) Ischaemia (1) Lung cancer (4) Malignant brain tumor (1) Melanoma (1) Myelodysplastic syndrome (MDS) (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (2) NSAID-associated gastric ulcer (1) Osteoarthritis (OA) (1) Psoriasis (1) Pulmonary embolism (1) Reflux esophagitis (1) Solid tumours (3) Type 2 diabetes (4) Ulcerative colitis (1) Urinary tract infections (1) Nosocomial Pneumonia (NP) (1) Systemic bacterial infections (1) Stroke (1) Malignant glioma (1) Relapsed or refractory malignant lymphoma (1) Neurotrophic Keratitis (NK) (1) Glioma (1) Esophageal squamous cell carcinoma (1) Alopecia (1) Corneal disorders (1) Bacterial infection (1) Diabetic neuropathy (1) Liver cancer (1) Inflammation (1) Benign prostatic hyperplas-lower urinarytract symptoms (1) Stomatitis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top